Abstract
Speedup of present high-molecular drug derivatives developments is based on the computational methods harmonic application. Such glycosidase as hyaluronidase has been functionated among multifarious glycosaminoglycan microenvironment in blood circulation of organism. It is important for elucidation of action mechanism of biosystem components (on vascular wall) and productive obtaining of hyaluronidase derivatives of cardiological destination the using of computer aided calculations for investigation of protein-glycosaminoglycan interactions. The aim of our study became the molecular docking fulfillment for 3D model of bovine testicular hyaluronidase with short-chain dimer and trimer chondroitin ligands. We used the molecular docking of hyaluronidase with chondroitin ligands for theoretical determination of biocatalyst conformational stability. At temperatures higher than 300 K free/native hyaluronidase (without ligands) displayed conformational transitions leading to its inactivation. Predominant manifestation of these transitions was an irreversible attraction developing between the protein area proximate to Glu-105, on the one hand, and to Arg-59 and Arg-96, on the other. Lowering of temperature did not restore the initial 3D structure of hyaluronidase. Binding of chondroitin ligands at ch 6, ch 3 and ch 1 sites stabilized the enzyme, increasing its denaturation temperature by 10°C. The highest degree of stabilization was achieved after chondroitin binding to ch 6. This effect was higher than that for chondroitin sulfate trimers concerning the enzyme inhibition by heparin tetramer, which requires binding of 4-5 chondroitin sulfate ligands to the enzyme surface. Molecular docking of 3D model of bovine testicular hyaluronidase with chondroitin dimers and trimers has revealed eight sites for their binding to the enzyme surface. At biological concentrations of these ligands the most important binding sites for them are ch 6, ch 3 and ch 1. Binding at these sites induces a reversible deformation of the protein 3D structure. Interactions between 3D model of bovine hyaluronidase with chondroitin ligands are based predominantly on electrostatic forces. Chondroitin ligands stabilized 3D structure of hyaluronidase after binding predominantly at chondroitin 6 as well as chondroitin 3 and chondroitin 1 positions and their effect was higher than chondroitin sulfate upon enzyme inhibition by heparin tetramer. Stabilizing effects of chondroitin and chondroitin sulfate ligands are fundamental for further direct theoretical comparative investigation of impact produced by these ligands.
Highlights
The use of high-molecular-weight compounds opened a new page in the development of drug therapeutic strategies against a wide variety of human diseases
Earlier we constructed the 3D model of native bovine testicular hyaluronidase (BTH) [15] and used this model for molecular docking with CH ligands. 3D-model of free BTH was docked with CH dimer and trimer using UCSF Chimera and DOCK software [16,17,18]
BTH surface was saturated with CH at a maximum binding of 4 ligands per molecule
Summary
The use of high-molecular-weight compounds opened a new page in the development of drug therapeutic strategies against a wide variety of human diseases. Vascular endothelium and its glycocalyx have been considered as double protective stratum of vessel lumen at present [8, 9] These developments prompted us to use consecutive molecular docking for modeling (computer simulation) of interactions between hyaluronidase, an enzyme involved in regulations of the glycocalyx, and glycosaminoglycans of its native microenvironment. HP inactivates BTH by entering the enzyme active site, while CHS produces a protective effect by occupying 4-5 binding sites, which abolishes BTH inactivation by HP This finding demonstrates that BTH stability is regulated by competitive binding of various ligands based predominantly on electrostatic forces. The goal of our investigation was the perform of molecular docking for 3D model of bovine testicular hyaluronidase with dimer and trimer chondroitin ligands for elucidation of functioning regulation this enzyme among short-chain glycosaminoglycan fragments of biocatalyst microenvironment
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.